Anna Forsyth1, Rebecca McMillan1, Doug Campbell2, Gemma Malpas2, Elizabeth Maxwell2, Jamie Sleigh3, Juergen Dukart4, Joerg F Hipp4, Suresh D Muthukumaraswamy5. 1. School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland, 92019, New Zealand. 2. Department of Anaesthesiology, Auckland District Health Board, Auckland, New Zealand. 3. Department of Anaesthesiology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand. 4. Roche Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center, F Hoffman La Roche, Basel, Switzerland. 5. School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland, 92019, New Zealand. sd.muthu@auckland.ac.nz.
Abstract
RATIONALE AND OBJECTIVES: The identification of biomarkers of drug action can be supported by non-invasive brain imaging techniques, such as electroencephalography (EEG) and functional magnetic resonance imaging (fMRI), with simultaneous collection plausibly overcoming the limitations of either modality alone. Despite this, few studies have assessed the feasibility and utility of recording simultaneous EEG/fMRI in a drug study. METHODS: We used simultaneous EEG/fMRI to assess the modulation of neural activity by ketamine and midazolam, in a placebo-controlled, single-blind, three-way cross-over design. Specifically, we analysed the sensitivity and direction of the spectral effects of each modality and the temporal correlations between the modulations of power of the common EEG bands and the blood-oxygen-level-dependent (BOLD) signal. RESULTS AND CONCLUSIONS: Demonstrating feasibility, local spectral effects were similar to those found in previous non-simultaneous EEG and fMRI studies. Ketamine administration resulted in a widespread reduction of BOLD fractional amplitude of low frequency fluctuations (fALFF) and a diverse pattern of effects in the different EEG bands. Midazolam increased fALFFin occipital, parietal, and temporal areas, and frontal delta and beta EEG power. While EEG spectra were more sensitive to pharmacological modulations than the fALFF bands, there was no clear spatial relationship between the two modalities. Additionally, ketamine modulated the temporal correlation strengths between the theta EEG band and the BOLD signal, whereas midazolam altered temporal correlations with the alpha and beta bands. Taken together, these results demonstrate the utility of simultaneous recording: each modality provides unique insights, and combinatorial analyses elicit more information than separate recordings.
RCT Entities:
RATIONALE AND OBJECTIVES: The identification of biomarkers of drug action can be supported by non-invasive brain imaging techniques, such as electroencephalography (EEG) and functional magnetic resonance imaging (fMRI), with simultaneous collection plausibly overcoming the limitations of either modality alone. Despite this, few studies have assessed the feasibility and utility of recording simultaneous EEG/fMRI in a drug study. METHODS: We used simultaneous EEG/fMRI to assess the modulation of neural activity by ketamine and midazolam, in a placebo-controlled, single-blind, three-way cross-over design. Specifically, we analysed the sensitivity and direction of the spectral effects of each modality and the temporal correlations between the modulations of power of the common EEG bands and the blood-oxygen-level-dependent (BOLD) signal. RESULTS AND CONCLUSIONS: Demonstrating feasibility, local spectral effects were similar to those found in previous non-simultaneous EEG and fMRI studies. Ketamine administration resulted in a widespread reduction of BOLD fractional amplitude of low frequency fluctuations (fALFF) and a diverse pattern of effects in the different EEG bands. Midazolam increased fALFF in occipital, parietal, and temporal areas, and frontal delta and beta EEG power. While EEG spectra were more sensitive to pharmacological modulations than the fALFF bands, there was no clear spatial relationship between the two modalities. Additionally, ketamine modulated the temporal correlation strengths between the theta EEG band and the BOLD signal, whereas midazolam altered temporal correlations with the alpha and beta bands. Taken together, these results demonstrate the utility of simultaneous recording: each modality provides unique insights, and combinatorial analyses elicit more information than separate recordings.
Entities:
Keywords:
Electroencephalography; Frequency analysis; Functional magnetic resonance imaging; Ketamine; Midazolam; Simultaneous EEG/fMRI
Authors: David J Greenblatt; Eric Legangneux; Jerold S Harmatz; Estelle Weinling; Jon Freeman; Kathleen Rice; Gary K Zammit Journal: J Clin Pharmacol Date: 2006-12 Impact factor: 3.126
Authors: Zhongming Liu; Jacco A de Zwart; Bing Yao; Peter van Gelderen; Li-Wei Kuo; Jeff H Duyn Journal: Neuroimage Date: 2012-08-17 Impact factor: 6.556
Authors: Owen Carmichael; Adam J Schwarz; Christopher H Chatham; David Scott; Jessica A Turner; Jaymin Upadhyay; Alexandre Coimbra; James A Goodman; Richard Baumgartner; Brett A English; John W Apolzan; Preetham Shankapal; Keely R Hawkins Journal: Drug Discov Today Date: 2017-11-15 Impact factor: 7.851
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: Joshua H Balsters; Redmond G O'Connell; Mary P Martin; Alessandra Galli; Sarah M Cassidy; Sophia M Kilcullen; Sonja Delmonte; Sabina Brennan; Jim F Meaney; Andrew J Fagan; Arun L W Bokde; Neil Upton; Robert Lai; Marc Laruelle; Brian Lawlor; Ian H Robertson Journal: PLoS One Date: 2011-09-08 Impact factor: 3.240
Authors: Rachael L Sumner; Rebecca L McMillan; Alexander D Shaw; Krish D Singh; Fred Sundram; Suresh D Muthukumaraswamy Journal: Hum Brain Mapp Date: 2018-04-17 Impact factor: 5.038
Authors: Anna E M Forsyth; Rebecca McMillan; Juergen Dukart; Jörg F Hipp; Suresh D Muthukumaraswamy Journal: Brain Topogr Date: 2021-10-13 Impact factor: 3.020
Authors: Bhim M Adhikari; Juergen Dukart; Joerg F Hipp; Anna Forsyth; Rebecca McMillan; Suresh D Muthukumaraswamy; Meghann C Ryan; L Elliot Hong; Simon B Eickhoff; Neda Jahandshad; Paul M Thompson; Laura M Rowland; Peter Kochunov Journal: Hum Brain Mapp Date: 2019-10-21 Impact factor: 5.038
Authors: Steven P Brandt; Elisa C Walsh; Laura Cornelissen; Johanna M Lee; Charles Berde; Erik S Shank; Patrick L Purdon Journal: Anesth Analg Date: 2020-10 Impact factor: 6.627